FABIOR is a Topical Aerosol, Foam in the Human Prescription Drug category. It is labeled and distributed by Mayne Pharma. The primary component is Tazarotene.
| Product ID | 51862-295_212adf24-4b84-46c7-8e2d-87048ed0077f |
| NDC | 51862-295 |
| Product Type | Human Prescription Drug |
| Proprietary Name | FABIOR |
| Generic Name | Tazarotene |
| Dosage Form | Aerosol, Foam |
| Route of Administration | TOPICAL |
| Marketing Start Date | 2017-03-10 |
| Marketing Category | NDA / NDA |
| Application Number | NDA202428 |
| Labeler Name | Mayne Pharma |
| Substance Name | TAZAROTENE |
| Active Ingredient Strength | 1 mg/g |
| Pharm Classes | Retinoid [EPC],Retinoids [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2017-03-17 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA202428 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | GM |
| Marketing Start Date | 2017-03-10 |
| Marketing Category | NDA |
| Application Number | NDA202428 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | GM |
| Marketing Start Date | 2017-03-17 |
| Ingredient | Strength |
|---|---|
| TAZAROTENE | 1 mg/g |
| SPL SET ID: | ae0afed7-1d60-45fd-a08b-8db094618521 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 51862-295 | FABIOR | tazarotene |
| 0187-2098 | Arazlo | tazarotene |
| 0023-9236 | AVAGE | tazarotene |
| 0168-0454 | TAZAROTENE | tazarotene |
| 0713-0670 | Tazarotene | Tazarotene |
| 0713-0764 | Tazarotene | Tazarotene |
| 0713-0804 | TAZAROTENE | tazarotene |
| 0713-0805 | TAZAROTENE | tazarotene |
| 51672-1373 | Tazarotene | Tazarotene |
| 51672-1374 | Tazarotene | Tazarotene |
| 60758-556 | Tazarotene | Tazarotene |
| 60758-561 | Tazarotene | Tazarotene |
| 68308-685 | tazarotene | tazarotene |
| 68308-745 | Tazarotene | TAZAROTENE |
| 0168-0455 | Tazarotene Cream | tazarotene |
| 0023-0042 | TAZORAC | tazarotene |
| 0023-8335 | TAZORAC | tazarotene |
| 0023-9155 | TAZORAC | tazarotene |
| 0023-9156 | TAZORAC | tazarotene |
| 16110-042 | Tazorac | tazarotene |
| 16110-833 | Tazorac | tazarotene |
| 16110-915 | TAZORAC | tazarotene |
| 16110-916 | TAZORAC | tazarotene |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() FABIOR 85694766 not registered Dead/Abandoned |
Stiefel Laboratories, Inc. 2012-08-03 |
![]() FABIOR 85210951 4436861 Live/Registered |
Glaxo Group Limited 2011-01-05 |
![]() FABIOR 78438372 not registered Dead/Abandoned |
Glaxo Group Limited 2004-06-21 |
![]() FABIOR 77632495 not registered Dead/Abandoned |
Glaxo Group Limited 2008-12-12 |